s6y

Celularity Inc

Ticker
CELU
CIK
1752828
Industry
Pharmaceutical Preparations
Formerly
GX Acquisition Corp.

Financials 46

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-K/A Annual Report for period ending Dec 31, 2025
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2026
  6. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  7. 10-K Annual Report for period ending Dec 31, 2025
  8. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  9. 10-Q Quarterly Report for period ending Sep 30, 2025
  10. 10-Q Quarterly Report for period ending Jun 30, 2025

All 46 financials filings

News 123

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 123 news filings

Ownership 227

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 227 ownership filings

Prospectus 84

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. RW Registration Withdrawal Request
  7. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 84 prospectus filings

Proxies 16

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

All 16 proxies filings

Other 68

  1. ARS Annual report to security holders
  2. SCHEDULE 13D/A
  3. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  4. SCHEDULE 13D/A
  5. SCHEDULE 13D/A
  6. SCHEDULE 13D
  7. SCHEDULE 13G/A
  8. EFFECT Notice of Effectiveness
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. UPLOAD Letter (PDF)

All 68 other filings